AcrySof IQ PanOptix trifocal IOL [Image from Alcon]
AcrySof IQ PanOptix trifocal intraocular lens
Alcon
Alcon’s AcrySof IQ PanOptix trifocal intraocular lens is touted as one of the only trifocal devices in the U.S. for patients undergoing cataract surgery.
Fort Worth, Texas–based Alcon designed the device to provide a combination of improved near, immediate and distance vision, significantly reducing the wearer’s need for glasses after surgery.
The AcrySof IQ PanOptix trifocal IOL won FDA approval in August 2019.
